News

NextTrip Strengthens Financial Position with the Conversion of $2.6 Million in Short-Term Debt to Restricted Equity Before its Fiscal Year-End

Provides for a Stronger Balance Sheet and Greater Financial Flexibility to Focus on Scaling Innovative Travel Solutions SANTA FE, NM / ACCESS Newswire / February 28, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a leading travel technology company, announced today the conversion of $2.6 million in short-term debt, including $1.5 million previously advanced by the Company's Chairman and CEO. These loans were converted into restricted equity ahead of completion of the Company's fiscal year-ended February 28, 2025.

02/28/2025

NextTrip and Blue Fysh Announce Strategic Partnership and Share Exchange Agreement to Drive Mutual Growth

Enables Expanded Audience Reach, Increased Advertising Revenue, Enhanced Sales Efforts, Increased Brand Awareness and Other Strategic Partnership Opportunities SUNRISE, FL / ACCESS Newswire / February 27, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a leading travel technology company, and Blue Fysh Holdings Inc. (Blue Fysh), a premier provider of digital out-of-home ("OOH") media solutions, announced today that they have entered into a strategic partnership and share exchange agreement. This collaboration is designed to unlock significant commercial benefits for both companies by creating minority ownership between the entities.

02/27/2025

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is NextTrip, Inc. (NTRP) a buy, sell, or hold?

NextTrip, Inc. (NTRP) can sell. Click on Rating Page for detail.

What is NextTrip, Inc.'s stock price?

The price of NextTrip, Inc. (NTRP) is 4.1215 and it was updated on 2025-03-17 09:00:36.

Is NextTrip, Inc. (NTRP) overvalued or undervalued?

Currently NextTrip, Inc. (NTRP) is in undervalued.

News

From:

To:

News
NextTrip Appoints John McMahon as Chief Operating Officer - Travel, Expands into Cruise Industry with Five Star Alliance Proven Industry Leader Brings Deep Relationships and Extensive Expertise Across all Facets of Leisure, Travel and Tourism Five Star Alliance Now Directing Group Booking Inquiries to NextTrip NextTrip to Launch New Cruise Booking Engine in the First Half of 2025 SUNRISE, FL / ACCESS Newswire / February 25, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a leading travel technology company, today announced the appointment of John McMahon, Chief Executive Officer and majority shareholder of Five Star Alliance ("FSA"), as NextTrip's Chief Operating Officer - Travel Division. With a proven track record in the leisure, travel, and tourism industry, McMahon brings extensive expertise in management, marketing strategy, digital marketing, online distribution, social media, and business development. Tue, Feb. 25, 2025
NextTrip Closes on 49% Stake in Five Star Alliance Secures Option to Acquire Full Ownership SANTA FE, NM / ACCESS Newswire / February 11, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip" or the "Company"), a leading travel technology company, today announced it has closed its previously announced acquisition of a 49% stake in Five Star Alliance, a premier luxury travel agency. As part of the transaction, NextTrip has secured an option to acquire full ownership of Five Star on or before April 7, 2025, subject to certain conditions. Tue, Feb. 11, 2025
NextTrip Invests in Luxury Travel Brand Five Star Alliance to secure 49% Stake with an Option to Purchase a Controlling Interest Transaction Expected to Strengthen NextTrip's Platform, Unlocks New Integration and Growth Opportunities Five Star Senior Management to Join NextTrip to Help Define Key Areas of Synergy and Revenue Acceleration in Both Travel and Media SANTA FE, NM / ACCESS Newswire / February 6, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a leading travel technology company, today announced it has signed definitive agreements to purchase 49% of the membership interests of Five Star Alliance. Additionally, subject to the satisfaction of certain conditions, the agreement provides NextTrip with an option to purchase a controlling interest in Five Star Alliance by April 7, 2025. Thu, Feb. 06, 2025
NextTrip Plans to Acquire Luxury Travel Company Five Star Alliance One of Trustpilot's Top-rated Travel Brands Brings its Proprietary Search Engine, Luxury Cruise Program, and Group Travel Pipeline, Along with Access to Additional Travel Agencies Acquisition is Highly Synergistic and Expected to Drive Growth SANTA FE, NM / ACCESSWIRE / November 5, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "company"), a leading travel technology company, announced today that it has signed a non-binding Letter of Intent (LOI) to acquire Five Star Alliance, an online luxury travel agency founded in 2004 and renowned for its curated collection of five-star luxury hotels and resorts worldwide. Key Five Star assets include: Proprietary search engine collecting the best rates at 5,000+ luxury hotels and resorts worldwide Established relationships of preferred suppliers and industry leaders Luxury cruise program Group travel pipeline 20-year reputation and authority Five Star Alliance specializes in helping travelers discover and book the world's top luxury hotels, offering personalized recommendations, competitive rates, and is known for world-class customer service. Tue, Nov. 05, 2024
NextTrip Prepares Compass.tv for Soft Launch, Signs New Content Creators Seamlessly Translates Content into Commerce Opportunities using the NextTrip Booking Engine SANTA FE, NM / ACCESSWIRE / October 1, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel technology company, announced today the launch of its owned and operated Compass.tv travel discovery channel and app. The platform initially features over a thousand hours of travel video content designed to seamlessly convert into commerce opportunities, allowing viewers to book vacations directly through the channel using the NextTrip Booking Engine. Tue, Oct. 01, 2024

Press Releases

StockPrice Release
Nexttrip strengthens financial position with the conversion of $2.6 million in short-term debt to restricted equity before its fiscal year-end 02/28/2025
Nexttrip and blue fysh announce strategic partnership and share exchange agreement to drive mutual growth 02/27/2025
Nexttrip appoints john mcmahon as chief operating officer - travel, expands into cruise industry with five star alliance 02/25/2025
Nexttrip closes on 49% stake in five star alliance 02/11/2025
Nexttrip invests in luxury travel brand five star alliance to secure 49% stake with an option to purchase a controlling interest 02/06/2025
Nexttrip plans to acquire luxury travel company five star alliance 11/05/2024
Nexttrip prepares compass.tv for soft launch, signs new content creators 10/01/2024
Nexttrip introduces group booking technology platform to streamline and simplify travel for groups 07/30/2024
Nexttrip, inc. receives nasdaq notification regarding late 10-q filing and continued listing requirements 07/19/2024
Nexttrip taps dooya media group to launch compass.tv 07/18/2024
Nexttrip launches flexpay travel payment options for bookings 07/11/2024
Nexttrip, inc receives nasdaq notification regarding late 10k filing and continued listing requirements 06/21/2024
Nexttrip engages mz group to lead strategic investor relations and shareholder communications program 04/02/2024
Global niemann-pick disease market and competitive landscape (2020 to 2024) - researchandmarkets.com 08/28/2020

More Headlines

News
NextTrip Introduces Group Booking Technology Platform to Streamline and Simplify Travel for Groups New Flexible Solution Designed to Reduce Friction, Empowering Customers When Reserving Group Travel SUNRISE, FL / ACCESSWIRE / July 30, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel technology company, today announced the launch of a new Group Booking Platform ("Platform"), a proprietary technology for its direct-to-consumer travel booking website offering travelers and facilitators a flexible and versatile solution for group travel. NextTrip's Platform streamlines front-end booking flow for customers, empowering each traveler to book their own travel while still remaining part of a group. 07/30/2024
NextTrip, Inc. Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements SUNRISE, FL / ACCESSWIRE / July 19, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel technology company, received a notice (the "Notice") from the listing qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") on July 17, 2024 stating the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended May 31, 2024. Additionally, the Company has not yet filed its Annual Report on Form 10-K for the fiscal year ended February 29, 2024. 07/19/2024
NextTrip Taps Dooya Media Group To Launch Compass.TV Dynamic Content-to-Commerce FAST Channel Reinvents Monetization Models SUNRISE, FL / ACCESSWIRE / July 18, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel technology company, today announced that it has partnered with OTT ("over-the-top") services company Dooya Media Group (DMG) to deliver Compass.TV, an owned and operated travel discovery channel and app that seamlessly translates content into commerce opportunities using the NextTrip Booking Engine. The channel aims to be the premier go-to source for travel information, inspiration, and entertainment. 07/18/2024
NextTrip Launches FlexPay Travel Payment Options for Bookings Allows Consumers to Pay for Accommodations Through Interest-free Installments with Convenient and Flexible Payment Options when Booking Travel Seamless Integration Enables Marketing Opportunities in Social Media Travel Package Campaigns and Direct-to-Consumer Marketing Channels to Drive Sales and Conversion Rates SUNRISE, FL / ACCESSWIRE / July 11, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel technology company, today announced the launch of FlexPay, a proprietary technology for its direct-to-consumer travel booking website giving customers new flexible payment options and exclusive deals. FlexPay is a flexible form of short-term financing that allows customers to pay for accommodations over time through interest-free installments. 07/11/2024
NextTrip, Inc Receives Nasdaq Notification Regarding Late 10K Filing and Continued Listing Requirements SUNRISE, FL / ACCESSWIRE / June 21, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip", "we," "our," or the "Company"), a travel technology company, has received a notice (the "Notice") from the listing qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of the delinquency in the timely filing of the Company's annual report on Form 10-K for the fiscal year ended February 29, 2024 (the "10-K"), the Company is out of compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the "SEC"). In accordance with Nasdaq's listing rules, the Company has 60 calendar days after the date of the Notice to submit a plan to regain compliance with respect to the delinquent 10-K filing. 06/21/2024
NextTrip Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program SUNRISE, FL / ACCESSWIRE / April 2, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip", "we," "our," or the "Company"), a travel technology company, has engaged international investor relations specialists MZ Group (MZ) to lead a comprehensive strategic investor relations and financial communications program across all key markets. MZ Group will work closely with NextTrip management to develop and implement a comprehensive capital markets strategy designed to increase the Company's visibility throughout the investment community. 04/02/2024
Is Neurotrope, Inc. (NTRP) A Good Stock To Buy According To Hedge Funds? Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback the hedge funds employing these talents and can benefit from their vast resources and knowledge in that way. We analyze quarterly 13F filings of nearly 817 hedge funds and, by looking at the smart money sentiment that surrounds a stock, we can determine whether it has the potential to beat the market over the long-term. Therefore, let's take a closer look at what smart money thinks about Neurotrope, Inc. (NASDAQ:NTRP). 11/27/2020
Global Niemann-Pick Disease Market and Competitive Landscape (2020 to 2024) - ResearchAndMarkets.com The 08/28/2020
Pendemo antikomunis ejek staf konsulat China di Houston Staf berkewarganegaraan China meninggalkan konsulatnya di Houston di tengah kerumunan massa yang melontarkan ejekan pada Jumat setelah pemerintah Amerika ... 07/25/2020
Homes plan rejected after marathon council meeting Phase two development for 169 homes hits dead end 07/02/2020
"Give our money back" for cancelled school trip A row has broken out after parents from 15 Perthshire schools have been made to wait for refunds due to them after outdoor activity trips were cancelled due to COVID-19. 06/30/2020
Council to consider changing weedkillier amidst bee fears Glyphosates are widely used around the world, but concerns have been raised they could be carcinogenic. 06/30/2020
Council apologises for "confusion" over completion certificates at development The apology comes after a curious resident claimed to have found dozens of people within Persimmon Homes’ controversial Lathro Meadows development did not have full completion certificates to show their houses meet building standards. 06/30/2020
Councillors set to approve nearly 200 more homes at controversial development Planning officials have recommended councillors approve Persimmon Homes’ application to press on with phase two of Lathro Meadows during a virtual meeting tomorrow despite locals raising 179 objections during two rounds of consultations. 06/30/2020
Pupuk Indonesia catat pemerintah utang subsidi Rp17,1 triliun PT Pupuk Indonesia (Persero) mencatat bahwa pemerintah masih memiliki utang berjalan Rp17,1 triliun yang harus dibayarkan ke BUMN Industri pupuk tersebut ... 06/29/2020
Perth and Kinross Council could be one of worst hit regions due to COVID-19 Statistics released to the BBC’s data unit say the financial impact could be £329 per resident in the region 06/26/2020
Perth and Kinross Council plans to scrap emergency powers Democratic decision-making like the time before COVID-19 became a threat is set to soon return to Perth and Kinross Council. 06/26/2020
Uncertainty on how schoolchildren will return full-time in August At a meeting of Perth and Kinross Council, the executive director of education and children’s services Sheena Devlininformed councillors details will be shared with parents and carers before the end of term. 06/25/2020
Neurotez: Can Leptin Prove Beneficial for Alzheimer's Patients? By Anita Dushyanth, PhD NASDAQ:INMB \| NASDAQ:NTRP \| TSX:PMN.TO Rethinking the approach to treat Alzheimer’s disease Both scientists and physicians are still wrestling with the idea of how to identify the biological drivers that are responsible for the early onset of neurodegenerative diseases. Alzheimer’s disease (AD), in particular, is extremely challenging to treat because it develops slowly 06/24/2020
Ideaya Biosciences Is Risky But Also Compelling If you've got the stomach for volatility, the potential oncology breakthroughs underlining IDYA stock makes for a very interesting pick. 06/23/2020
Pupils will be asked to wear clean clothes every day when they return to school But some pupils might attend classes as little as once a week when they reopen. 06/23/2020
Ten schools could reopen fully in August The children and young people spokesperson for COSLA (Convention of Scottish Local Authorities) Cllr Stephen McCabe revealed PKC’s plans live on Radio Scotland on Thursday morning. 06/23/2020
Abernyte school legal proceedings bill not made public A FOI request to find out how much it cost Perthshire taxpayers for the local authority to try to stop a court inquiry into a school closure has drawn a blank. 06/19/2020
Scottish Crannog Centre secures land transfer to expand Loch Tay could soon have a village of pre-historic crannogs along the north shore following a land transfer that will allow an expansion of an already popular site. 06/18/2020
Perth and Kinross Council promises summer school meals cash There's help this summer to keep children who depend on free school meals from going hungry. 06/16/2020
INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - FNJN, NTRP, GRUB NEW YORK, NY / ACCESSWIRE / June 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP ... 06/12/2020
Riding school to rise from ashes as bid to replace facilities is approved The proposal drew support from several pony clubs during a public consultation but also drew criticism from local residents 06/12/2020
Neurotrope Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the National Cancer Institute (NCI) Trial for Childhood Leukemia Neurotrope, Inc. (Nasdaq: NTRP) ("Neurotrope" or the "Company") today announced its entry into a strategic agreement with BryoLogyx Inc., www.BryoLogyx.com, for the supply of synthetic, GMP-certified Bryostatin-1, manufactured by Albany Molecular Research, Inc. ("AMRI"), a leading global CDMO provider of advanced drug development and manufacturing solutions. Neurotrope expects to use the synthetic Bryostatin-1 in its clinical development initiatives aimed at advancing its lead product candidate for the treatment of Alzheimer's disease ("AD") and other neurodegenerative diseases and, ultimately, as a source for potential commercial drug supply if regulatory approval is received. 06/10/2020
Sensex, Nifty log narrow gains to end up for 6th session; M&M, Kotak Bank rally Indian stocks closed nearly 1% higher for the sixth consecutive session on Wednesday lead by healthy buying in financials.After hitting an intraday high of 34,488.69 points, Sensex ended 284 points or 0.8% higher at 34,109.54, while Nifty closed 82 points or 0.83% higher at 10,061.55 06/03/2020
Cek fakta: Benarkah militer China masuk ke Indonesia sebagai pekerja proyek? Sebuah pesan tentang militer asal China yang menyamar sebagai pekerja proyek di Indonesia beredar di media jejaring sosial Facebook. Pesan itu mengklaim ... 06/02/2020
New group aiming to make Perth a safer place for cyclists and pedestrians Perth Area Living Streets members hope roads officers will consider implementing at least some of their recommendations in the near future 05/29/2020
Perth and Kinross councillor launches passionate defence of Dominic Cummings Councillor Ian James also attacked the media, branding it "politically-biased" 05/29/2020
Neurotrope Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Patients with Alzheimer's Disease Neurotrope, Inc. (Nasdaq: NTRP) today announced the launch of a new long-term study of Bryostatin-1 for the treatment of patients with Alzheimer's disease (AD). The Phase 2 clinical study will be conducted in collaboration with the National Institutes of Health (NIH) under a $2.7 million grant to Neurotrope. After reviewing the data from the previous trial with Key Opinion Leaders and the NIH, we designed a study to evaluate the long-term therapeutic effect of Bryostatin-1 in the absence of Namenda® (memantine) in patients with AD. The Company has engaged Worldwide Clinical Trials to initiate site recruitment and activation. 05/28/2020
Neurotrope Announces Investor Update Conference Call Neurotrope, Inc. (Nasdaq: NTRP) today announced that it will host an investor conference call and webcast to give an update on Bryostatin and the recently proposed merger between Neurotrope and Metuchen Pharmaceuticals, L.L.C. to form Petros Pharmaceuticals, Inc. The investor call is scheduled for Thursday, May 28, 2020 at 11:00 AM ET. 05/26/2020
Twice as many Perth and Kinross residents are asking for crisis cash Welfare grant applications have soared 05/26/2020
PKC could decide on major planning applications without public present Kinross-shire councillor Willie Robertson said last week he was concerned the local authority’s planning committee could determine Persimmon Homes’ latest application involving its controversial Lathro Meadows development during a virtual meeting scheduled for July 1. 05/26/2020
Perth and Kinross sports clubs prepare to welcome players back Recycling centres also to reopen from Thursday (May 28) 05/25/2020
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - WMGI, MINI, NTRP NEW YORK, NY / ACCESSWIRE / May 20, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek ... 05/20/2020
Fears of 'carmageddon' in Perth when emerging from coronavirus lockdown Walkers and cyclists may be put at risk 05/19/2020
Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company Neurotrope, Inc. (Nasdaq: NTRP) and Metuchen Pharmaceuticals, L.L.C., a privately held biopharmaceutical company ("Metuchen"), focused on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health conditions, today announced that the two companies have entered into a definitive merger agreement under which Metuchen and Neurotrope, Inc. ("Neurotrope") will merge in an all-stock transaction resulting in a newly formed holding company to be renamed Petros Pharmaceuticals, Inc. ("Petros"). Petros is expected to become a Nasdaq traded company focused solely on men's health conditions. Petros' cornerstone product would be Metuchen's Stendra® (avanafil) for erectile dysfunction ("ED"). Petros' pipeline would include Metuchen's recently in-licensed product H-100 for Peyronie's disease, and it would include a business development program exploring various men's health products, including endothelial dysfunction, prostate cancer, psychosexual and psychosocial ailments, hormone health and substance use disorders. 05/18/2020
IDEAYA BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) \| MarketScreener 05/12/2020
China ejek AS lewat animasi mirip lego "Once Upon a Virus" China merilis film animasi pendek berjudul "Once Upon a Virus" yang mengejek respons Amerika Serikat (AS) terhadap virus corona baru menggunakan ... 05/04/2020
Global Automotive Wire Market 2020 Key Players, Industry Overview, Supply Chain and Analysis to 2024 Apr 29, 2020 (The Expresswire) -- Global “Automotive Wire Market ” report presents a complete overview, market shares, and growth opportunities of market, by... 04/29/2020
Head-To-Head Analysis: Amphastar Pharmaceuticals (NASDAQ:AMPH) and Neurotrope (NASDAQ:NTRP) Amphastar Pharmaceuticals (NASDAQ:AMPH) and Neurotrope (NASDAQ:NTRP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk and profitability. Risk and Volatility Amphastar Pharmaceuticals has a beta of 1.11, meaning that its stock price is […] 04/07/2020
Lexicon Pharmaceuticals (NASDAQ:LXRX) versus Neurotrope (NASDAQ:NTRP) Head-To-Head Contrast Lexicon Pharmaceuticals (NASDAQ:LXRX) and Neurotrope (NASDAQ:NTRP) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk. Insider and Institutional Ownership 6.4% of Neurotrope shares are owned by institutional investors. 6.4% of Lexicon […] 03/23/2020
PKC forks out £97,000 for internet back-up Second provider for staff 03/19/2020
Do Directors Own Neurotrope, Inc. (NASDAQ:NTRP) Shares? We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made... 03/18/2020
Largest borrow rate increases among liquid names NTRP;ARLP;XBIT;CHNG;PTON;LABD;DO;WPG;X;I Largest borrow rate increases among liquid names NTRP ARLP XBIT CHNG PTON LABD DO WPG X I 02/18/2020
Car parks card issue is set to be resolved Machines at South Inch and Canal Street set to be back in business 02/14/2020
PKC budget set to bring more cuts Perth councillor fears there will be “more misery” for the region 02/11/2020
Largest borrow rate increases among liquid names NTRP;KALA;KL;ARLP;AG;CGC;PTON;CVE;INO;PAYS Largest borrow rate increases among liquid names NTRP KALA KL ARLP AG CGC PTON CVE INO PAYS 02/07/2020
XpresSpa Appoints Robert Weinstein to Board of Directors The Company has made plans for a smooth transition. Mr. Weinstein is a finance and accounting senior executive with over 30 years of “hands-on” public and private company management, investment banking and private equity investing experience. 02/03/2020
The Wuhan Coronavirus: 21 Stocks to Watch News like the Coronavirus can affect the stock market — either as a whole or just certain stocks and sectors. See how you can prepare. 01/29/2020
Why I Love Trading A Small Account, And Why You Should Too January is turning out to be a bit of a roller-coaster market for my main account. The last trade I took in the account on Wednesday in Neurotrope, Inc. (NASDAQ: NTRP) ended up netting me another $166 in the account. 01/24/2020
Neurotrope, Inc. Announces $18 Million Registered Direct Offering Neurotrope, Inc. (the "Company") (NASDAQ:NTRP) today announced that it has received commitments from institutional investors and pre-existing high net worth individuals to purchase an aggregate of $18 million of the Company's securities in a registered direct offering. 01/22/2020
Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease Trial Neurotrope, Inc. (Nasdaq: NTRP) ("Neurotrope" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, today announced its corporate update. 01/22/2020
Is Neurotrope, Inc. (NASDAQ:NTRP) A Volatile Stock? If you own shares in Neurotrope, Inc. (NASDAQ:NTRP) then it's worth thinking about how it contributes to the... 12/19/2019
'One of the biggest, baddest things we did': Black Panthers' free breakfasts, 50 years on The party’s program to feed kids, launched in 1969, became a national phenomenon. This weekend, former members joined a celebration in the party’s birthplace 10/18/2019
Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value NEW YORK, Oct. 8, 2019 /PRNewswire/ -- Neurotrope, Inc. (NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, today announced its plans to explore strategic alternatives to maximize shareholder value. "Following the results from our Phase 2 study of Bryostatin-1 in Alzheimer's disease, we believe a review of strategic alternatives is an important step toward preserving and enhancing shareholder value," stated Dr. Charles S. Ryan, Neurotrope's Chief Executive Officer. There can be no assurance that the formal strategic review of alternatives will result in any successful transaction or other outcome. 10/08/2019
Zynex (ZYXI) Scales 52-Week High: What's Driving the Stock? Zynex (ZYXI) is likely to maintain the current high on a number of favorable factors. 10/04/2019
Abbott (ABT) Gets FDA Nod for Spinal Cord Stimulation System Abbott (ABT) is upbeat about the latest clearance in its neuromodulation product portfolio. 10/01/2019
Medtronic's All Business Lines Grow Despite Cost Concerns Within Diabetes group, Medtronic (MDT) is seeing a strong adoption of the Guardian Connect Smart CGM system. 09/30/2019
Boston Scientific (BSX) Upbeat on Results of EVOLVE Study Boston Scientific (BSX) is hopeful about robust data outcome on DAPT study as the therapy duration might prove to be a superior treatment option. 09/30/2019
NuVasive Announces Innovations in Robotics Spine Surgery Line NuVasive (NUVA) aims to speed up the adoption of less invasive spine surgery through robotics. 09/27/2019
Align Gains on Innovation Despite Poor Case Shipment in China Align Technology (ALGN) succeeds in consecutively delivering a solid spurt in Invisalign Technology volumes across the company's entire clientele. 09/26/2019
Natera (NTRA) Scales 52-Week High: What's Driving the Stock? Natera (NTRA) is likely to maintain the current high on a number of favorable factors. 09/26/2019
FDA Nods to Medtronic's (MDT) New Age Evolut PRO+ TAVR This latest FDA approval of Medtronic's (MDT) Evolut PRO+ follows the last month's nod from the regulatory body for the Evolut TAVR system with regard to expanded indication. 09/24/2019
Insulet Receives FDA Approval for ACE Pump Implementation FDA's approval will enable Insulet (PODD) to boost its insulin management business. 09/24/2019
Mantan dirut BUMN China serahkan diri Mantan direktur utama salah satu badan usaha milik negara di Provinsi Hainan, China, menyerahkan diri di Beijing, Rabu (16/1), setelah hampir 16 tahun ... 01/17/2019
Karier Kepala Interpol berakhir di bui Laporan Grace Meng kepada kepolisian di Lyon, Prancis, Kamis (4/10), perihal kehilangan sang suami menyita perhatian dunia internasional. Pasalnya sang ... 10/09/2018
Prestasi KPK China menumpas korupsi pejabat Pimpinan lembaga antikorupsi Partai Komunis China mengumumkan bahwa 5.419 pejabat terjaring operasi yang digelar selama bulan Agustus 2017. Para pejabat ... 09/19/2017
Picture Keeper Connect review: Simple photo backup for the entire family A dual Lightning and USB thumb drive with mobile and desktop apps that make it easy to back up precious photos, videos, and contacts. 09/26/2016

Unlock

NTRP Ratings Summary

NTRP Quant Ranking

Is NextTrip, Inc. (NTRP) a buy, sell, or hold?

What is NextTrip, Inc.'s stock price?

Is NextTrip, Inc. (NTRP) overvalued or undervalued?

NextTrip Introduces Group Booking Technology Platform to Streamline and Simplify Travel for Groups

NextTrip, Inc. Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements

NextTrip Taps Dooya Media Group To Launch Compass.TV

NextTrip Launches FlexPay Travel Payment Options for Bookings

NextTrip, Inc Receives Nasdaq Notification Regarding Late 10K Filing and Continued Listing Requirements

NextTrip Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Is Neurotrope, Inc. (NTRP) A Good Stock To Buy According To Hedge Funds?

Global Niemann-Pick Disease Market and Competitive Landscape (2020 to 2024) - ResearchAndMarkets.com

Pendemo antikomunis ejek staf konsulat China di Houston

Homes plan rejected after marathon council meeting

"Give our money back" for cancelled school trip

Council to consider changing weedkillier amidst bee fears

Council apologises for "confusion" over completion certificates at development

Councillors set to approve nearly 200 more homes at controversial development

Pupuk Indonesia catat pemerintah utang subsidi Rp17,1 triliun

Perth and Kinross Council could be one of worst hit regions due to COVID-19

Perth and Kinross Council plans to scrap emergency powers

Uncertainty on how schoolchildren will return full-time in August

Neurotez: Can Leptin Prove Beneficial for Alzheimer's Patients?

Ideaya Biosciences Is Risky But Also Compelling

Pupils will be asked to wear clean clothes every day when they return to school

Ten schools could reopen fully in August

Abernyte school legal proceedings bill not made public

Scottish Crannog Centre secures land transfer to expand

Perth and Kinross Council promises summer school meals cash

INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - FNJN, NTRP, GRUB

Riding school to rise from ashes as bid to replace facilities is approved

Neurotrope Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the National Cancer Institute (NCI) Trial for Childhood Leukemia

Sensex, Nifty log narrow gains to end up for 6th session; M&M, Kotak Bank rally

Cek fakta: Benarkah militer China masuk ke Indonesia sebagai pekerja proyek?

New group aiming to make Perth a safer place for cyclists and pedestrians

Perth and Kinross councillor launches passionate defence of Dominic Cummings

Neurotrope Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Patients with Alzheimer's Disease

Neurotrope Announces Investor Update Conference Call

Twice as many Perth and Kinross residents are asking for crisis cash

PKC could decide on major planning applications without public present

Perth and Kinross sports clubs prepare to welcome players back

IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - WMGI, MINI, NTRP

Fears of 'carmageddon' in Perth when emerging from coronavirus lockdown

Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company

IDEAYA BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) | MarketScreener

China ejek AS lewat animasi mirip lego "Once Upon a Virus"

Global Automotive Wire Market 2020 Key Players, Industry Overview, Supply Chain and Analysis to 2024

Head-To-Head Analysis: Amphastar Pharmaceuticals (NASDAQ:AMPH) and Neurotrope (NASDAQ:NTRP)

Lexicon Pharmaceuticals (NASDAQ:LXRX) versus Neurotrope (NASDAQ:NTRP) Head-To-Head Contrast

PKC forks out £97,000 for internet back-up

Do Directors Own Neurotrope, Inc. (NASDAQ:NTRP) Shares?

Largest borrow rate increases among liquid names NTRP;ARLP;XBIT;CHNG;PTON;LABD;DO;WPG;X;I

Car parks card issue is set to be resolved

PKC budget set to bring more cuts

Largest borrow rate increases among liquid names NTRP;KALA;KL;ARLP;AG;CGC;PTON;CVE;INO;PAYS

XpresSpa Appoints Robert Weinstein to Board of Directors

The Wuhan Coronavirus: 21 Stocks to Watch

Why I Love Trading A Small Account, And Why You Should Too

Neurotrope, Inc. Announces $18 Million Registered Direct Offering

Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease Trial

Is Neurotrope, Inc. (NASDAQ:NTRP) A Volatile Stock?

'One of the biggest, baddest things we did': Black Panthers' free breakfasts, 50 years on

Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value

Zynex (ZYXI) Scales 52-Week High: What's Driving the Stock?

Abbott (ABT) Gets FDA Nod for Spinal Cord Stimulation System

Medtronic's All Business Lines Grow Despite Cost Concerns

Boston Scientific (BSX) Upbeat on Results of EVOLVE Study

NuVasive Announces Innovations in Robotics Spine Surgery Line

Align Gains on Innovation Despite Poor Case Shipment in China

Natera (NTRA) Scales 52-Week High: What's Driving the Stock?

FDA Nods to Medtronic's (MDT) New Age Evolut PRO+ TAVR

Insulet Receives FDA Approval for ACE Pump Implementation

Mantan dirut BUMN China serahkan diri

Karier Kepala Interpol berakhir di bui

Prestasi KPK China menumpas korupsi pejabat

Picture Keeper Connect review: Simple photo backup for the entire family

Company Details

Ratings

Quant Factor Grades

Trading

Dividend Grades